Artemisinin (Sweet Wormwood / Qinghao)
Ancient Text to Nobel Prize
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
This is the single clearest case of a traditional remedy validated by rigorous modern science. In a 1960s-70s Chinese program, the chemist Tu Youyou screened over 2,000 traditional recipes; the breakthrough came when an ancient instruction to steep the herb in cool water (rather than boil it) revealed that heat was destroying the active compound. Isolating pure artemisinin from sweet wormwood produced a malaria treatment that has saved millions of lives and became the global frontline therapy. Tu Youyou received the 2015 Nobel Prize in Physiology or Medicine, the first for a discovery drawn from traditional Chinese medicine. The validation is unambiguous: the tradition pointed to the plant; modern methods isolated, proved, and scaled the cure.
Reference only. Not medical advice.
What can go wrong
Given as combination therapy under medical guidance, artemisinin drugs are highly effective and generally well tolerated. The serious risks lie elsewhere. Using artemisinin alone (monotherapy) or relying on the raw herb or wormwood tea can deliver too little drug to clear the parasite, which fosters treatment failure and drug resistance, a documented and growing global concern. Substituting any unproven herbal antimalarial for proper treatment is dangerous because malaria can kill quickly. Anyone with possible malaria, especially children, pregnant people, and travelers returning from endemic regions, should seek urgent care from a qualified medical provider and be treated with a WHO-recommended regimen rather than self-medicating. This entry describes a validated pharmaceutical, not a home remedy.
Artemisinin is the story people reach for when they want to show that traditional medicine can point science toward something real. Sweet wormwood was used in China for intermittent fevers, what we would now call malaria, for more than sixteen centuries, first recorded in a handbook from around 340 CE. During a Cold War era Chinese research program, the chemist Tu Youyou screened thousands of traditional recipes, and an ancient instruction to prepare the herb in cold water told her that heat was destroying the active ingredient. Extracting pure artemisinin produced a drug that clears the malaria parasite faster than anything before it, and its combination therapies are now the world's frontline malaria treatment, work that earned Tu the 2015 Nobel Prize. Two points keep the entry honest: the validated medicine is the purified compound in combination, which is not the same as wormwood tea, and artemisinin resistance is a live and growing threat rather than a settled victory.
A 1,600-year-old Chinese fever remedy became the world's frontline malaria cure and won a Nobel Prize, the clearest proof that tradition can point science to something real.
How it works
Artemisinin and its derivatives are activated by iron in the malaria parasite, generating reactive molecules that rapidly kill it, faster than prior antimalarials and by a mechanism unique among them.
What people get wrong
Often saidTraditional remedies never lead to real medicines.
ActuallyArtemisinin is a direct counterexample. A Chinese fever remedy first recorded around 340 CE led, through Tu Youyou's Project 523 work, to the world's frontline malaria treatment and the 2015 Nobel Prize in Physiology or Medicine (NobelPrize.org). Tradition pointed to the plant; science isolated the compound and proved it in randomized trials.
Often saidSince wormwood cures malaria, wormwood tea is a safe self-treatment.
ActuallyThe validated medicine is purified artemisinin given as combination therapy under medical care. WHO advises against Artemisia annua teas and infusions because their artemisinin content is low and variable, delivering subtherapeutic doses that risk treatment failure and can drive resistance (WHO malaria program). Malaria is a medical emergency.
Often saidArtemisinin drugs have permanently solved malaria.
ActuallyThey transformed treatment but have not ended the disease. WHO confirms artemisinin partial resistance in Eritrea, Rwanda, Uganda and Tanzania, and a 2025 analysis of over 112,000 parasite samples found resistance-linked K13 mutations rising sharply in East Africa, mirroring Southeast Asia a decade earlier (eLife 2025).
Who profits, and who pushes back
The Nobel Assembly
Honored Tu Youyou for discovering artemisinin from traditional herbal medicine, a therapy that has saved millions of lives, the first Nobel for a TCM-derived discovery.
Tu Youyou
Drew the decisive insight from an ancient cold-extraction instruction, recognizing that heat destroyed the active compound, then isolated and tested pure artemisinin.
Global malaria community
Artemisinin-based combination therapy is the frontline malaria treatment worldwide; the concern now is preserving its efficacy against emerging resistance.
Resistance-stewardship caution
Artemisinin must be used in combination and under guidance; monotherapy and raw-herb use threaten the resistance that could undo its global benefit.
Where the research comes from
Most of the published research on this comes from one place. 100% of it is from Frontline malaria treatment worldwide. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| Frontline malaria treatment worldwide | 100% |
How we got here
Qinghao appears as a fever treatment in Chinese medical writing across roughly sixteen centuries, most famously in Ge Hong's fourth-century handbook Emergency Prescriptions Kept Up One's Sleeve. Its route into modern medicine began not in the West but inside China. In 1967, at the height of the Vietnam War and after a request relayed from North Vietnam, Chinese leadership launched a secret antimalarial effort called Project 523. Tu Youyou, a researcher at the Academy of Traditional Chinese Medicine in Beijing, took charge of the herbal branch in 1969 and combed the classical literature. Ge Hong's line about steeping the plant in cold water, rather than boiling it, was the clue that the compound was heat sensitive. Switching to a low-temperature ether extraction, her team isolated artemisinin in 1972. Chinese scientists published the work through the 1970s and 1980s, and the compound reached global malaria programs before Western institutions fully recognized it, culminating in the 2015 Nobel Prize.
- 340Ge Hong records qinghao in cold-water preparation for intermittent fevers (Emergency Prescriptions Kept Up One's Sleeve)
- 1967China launches secret antimalarial Project 523 on 23 May, spurred by drug-resistant malaria in the Vietnam War
- 1969Tu Youyou takes over the herbal research group and begins screening classical Chinese recipes
- 1972Tu Youyou's team isolates the active compound, qinghaosu (artemisinin), using low-temperature extraction
- 2005SEAQUAMAT trial shows intravenous artesunate cuts severe-malaria mortality versus quinine in Asian adults
- 2010AQUAMAT trial confirms artesunate reduces severe-malaria mortality in African children
- 2015Tu Youyou awarded the Nobel Prize in Physiology or Medicine, shared with Campbell and Omura
- 2024WHO reports artemisinin partial resistance confirmed or suspected in at least 8 African countries
How it is understood
Qinghao (Artemisia annua, sweet wormwood) appears in Chinese medical texts as a remedy for "intermittent fevers," the classic sign of malaria, including in Ge Hong's handbook of emergency prescriptions from roughly 317-420 AD. For some sixteen centuries it sat in the herbal record as a folk and classical remedy, used by practitioners who could not have known why it worked, only that it did.
At a glance
- Plant
- Artemisia annua (sweet wormwood / qinghao)
- First recorded
- ~317-420 AD (Ge Hong)
- Isolated by
- Tu Youyou (1970s)
- Nobel Prize
- 2015 (Physiology or Medicine)
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Artemisinin (Sweet Wormwood / Qinghao). A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What people take it for. We have not catalogued the claims made for it.
Sources
Tu Youyou awarded the 2015 Nobel Prize in Physiology or Medicine for artemisinin, shared with Campbell and Omura
Project 523 launched 23 May 1967; Tu took over herbal group 1969; Ge Hong text circa 340 CE gave cold-extraction clue; artemisinin isolated 1972
Nobel biography detail on Project 523, the ancient handbook clue, and Tu's discovery of a novel malaria therapy
ACTs recommended by WHO as first- and second-line treatment; artemisinin partial resistance definition, K13 marker, confirmed in Eritrea, Rwanda, Uganda, Tanzania; ACTs remain best available treatment
World Health Organization, Malaria: artemisinin partial resistance (Q&A)
AQUAMAT: artesunate reduced severe-malaria mortality in African children versus quinine (8.5% vs 10.9%, 22.5% relative reduction)
SEAQUAMAT: intravenous artesunate reduced severe-malaria mortality versus quinine in Asian adults (15% vs 22%)
Cochrane review supporting ACT efficacy above 95% for major regimens in uncomplicated malaria
Artemisinin-based combination therapy for treating uncomplicated malaria, Cochrane (via PMC)
K13 resistance mutations rising sharply in East Africa (e.g. Uganda ~1% in 2013 to 26% by 2022), mirroring Southeast Asia; 112,933 samples across 73 countries
Understanding the global rise of artemisinin resistance, eLife 2025 (via PMC)
Expanded malaria tools prevented an estimated 170 million cases and 1 million deaths in 2024; ~282 million cases and 610,000 deaths in 2024; resistance in at least 8 African countries
Whole-plant Artemisia annua retained activity against artemisinin-resistant parasites in a rodent model (contested basis for whole-plant use)
Dried whole-plant Artemisia annua slows evolution of malaria drug resistance, PNAS 2015